Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes

OBJECTIVE: To investigate serum intestinal fatty acid-binding protein (I-FABP) in two groups of patients with different duration of hyperglycemia in a cross-sectional study. MATERIALS AND METHODS: In the present study, a total of 280 individuals (158 outpatients and 122 inpatients) suffering from hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yifeng, Ding, Licheng, Yang, Jiayue, Liu, Lijun, Dong, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863777/
https://www.ncbi.nlm.nih.gov/pubmed/33604184
http://dx.doi.org/10.7717/peerj.10800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863777/
https://www.ncbi.nlm.nih.gov/pubmed/33604184
http://dx.doi.org/10.7717/peerj.10800

Ejemplares similares